oxymatrine has been researched along with Degenerative Disc Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ahati, P; Chen, Y; Dai, J; Ding, Q; Ding, Y; Fang, H; Pei, Y; Wang, H; Wang, Z; Wei, K; Zhou, X | 1 |
Ding, J; Ding, Y; Fang, H; Pei, Y; Tan, S; Wang, H; Wei, K; Zhang, C; Zhang, W; Zou, C | 1 |
2 other study(ies) available for oxymatrine and Degenerative Disc Disease
Article | Year |
---|---|
Oxymatrine suppresses IL-1β-induced degradation of the nucleus pulposus cell and extracellular matrix through the TLR4/NF-κB signaling pathway.
Topics: Alkaloids; Animals; Apoptosis; Cells, Cultured; Extracellular Matrix; Interleukin-1beta; Intervertebral Disc Degeneration; Matrix Metalloproteinases; NF-kappa B; Nucleus Pulposus; Quinolizines; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4 | 2020 |
Oxymatrine Liposomes for Intervertebral Disc Treatment: Formulation, in vitro and vivo Assessments.
Topics: Alkaloids; Animals; Apoptosis; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Hydrogen-Ion Concentration; Inflammation; Intervertebral Disc Degeneration; Liposomes; Mice; Mice, Inbred Strains; Molecular Structure; Particle Size; Quinolizines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Surface Properties | 2020 |